Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Human Immunodeficiency Virus (HIV) Tests Market Report Overview
The human immunodeficiency virus (HIV) tests market size was valued at $1.95 billion in 2023. The HIV test market will grow at a CAGR of more than 2% from 2023 to 2033. The Human Immunodeficiency Virus (HIV) has become one of the world’s most serious health issues affecting approximately 36.3 million people. In the first few weeks after attaining HIV, patients develop symptoms like fever, rash, sore throat, etc but as the infection progresses. they become nonimmune to a greater extent leading to a decrease in CD4 count and undergo symptoms like swollen lymph nodes, weight loss, fever, diarrhoea, and cough. It may result in the development of Immunodeficiency syndrome or severe illnesses such as cryptococcal meningitis, tuberculosis, severe bacterial infections, and cancers such as lymphomas and Kaposi’s sarcoma if left untreated for a long time.
HIV Tests Market Outlook 2023-2033 ($ Billion)
Buy the Full Report for More Insights on the HIV Tests Market Forecast, Download a Free Sample Report
The HIV tests market research report explains the market behavior, which will help identify quantitative market trends within in vitro diagnostics therapeutic areas. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies. The HIV tests market model also discusses the detailed impact of COVID-19 on the HIV tests market for 2020 and beyond.
Market Size (2023) | $1.95 billion |
CAGR (2023-2033) | >2% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments | · CD4 Count Tests
· HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests · HIV Nucleic Acid Amplification Tests (NAATs) · HIV Point of Care (POC) Tests |
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
HIV Tests Market Dynamics
HIV is an ongoing, global public health issue that remains a priority for most governments. HIV tests are performed for two purposes including the screening and diagnosis and the monitoring of HIV-positive patients, particularly those undergoing antiretroviral therapy (ART). A rise in HIV incidence is predicted to lead to a higher number of suspected infection cases being tested as well as improved disease awareness and continuation of strong screening initiatives. Additionally, the prevalence of the disease is also predicted to increase, and this is expected to bolster sales of HIV NAATs used to measure the viral load, as well as CD4 count tests.
The incidence of HIV is expected to increase in many countries during the forecast period. In each country, HIV test sales are influenced by a variety of factors including fluctuations in disease incidence, rising HIV prevalence, the number of pregnant women, sperm donations, blood donations, and source plasma donations.
Buy the Full Report for Additional Information on the HIV Tests Market Dynamics, Download a Free Sample Report
HIV Tests Market Segments
The key segments in the HIV tests market are CD4 Count Tests, HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests, HIV Nucleic Acid Amplification Tests (NAATs), and HIV Point of Care (POC) Tests. In 2023, the HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests segment dominated the HIV test market share. The segment will continue to retain its dominance during the projected period.
HIV Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Insights into the HIV Tests Market Segments, Download a Free Sample Report
HIV Tests Market Segmentation by Regions
The key regions in the HIV tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America led the global market with the US being the largest contributor to HIV tests sales. A large proportion of tests are performed on pregnant women and donors of human cells, tissues, and cellular and tissue-based products thereby driving the market growth. The US and Canadian HIV test markets will be driven by an increase in source plasma and whole blood donations, respectively. The number of pregnant women in these two countries is also expected to increase, further augmenting the HIV test market.
HIV Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights in the HIV Tests Market, Download A Free Sample Report
HIV tests Market – Competitive Landscape
The key companies in the HIV tests market are Abbott Laboratories, Becton Dickinson and Co, Danaher Corp, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd among others. In 2023, F. Hoffmann-La Roche Ltd accounted for the highest HIV tests market share and value.
HIV Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the HIV Tests Market, Download a Free Sample Report
Segments Covered in this Report.
HIV Tests Segment Outlook ($ Million, 2015-2033)
- CD4 Count Tests
- HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests
- HIV Nucleic Acid Amplification Tests (NAATs)
- HIV Point of Care (POC) Tests
HIV Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are –
Currently marketed HIV tests market and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total HIV tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the HIV tests market.
- Competitive dynamics insights and trends provided for the HIV tests market.
Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Becton Dickinson and Co, Danaher Corp, Bio-Rad Laboratories Inc, Hologic Inc, OraSure Technologies Inc, QuidelOrtho Corp, Oswaldo Cruz Foundation, Grifols SA, F. Hoffmann-La Roche Ltd, Siemens AG, Qiagen NV, Trinity Biotech Plc, and others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. The model will benefit the following stakeholders:
- CMO executives must have a deep understanding of the HIV tests marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to:
- Understand the impact of COVID-19 on HIV tests.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving HIV tests.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the HIV tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific HIV tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Becton Dickinson and Co
Danaher Corp
Bio-Rad Laboratories Inc
Hologic Inc
OraSure Technologies Inc
QuidelOrtho Corp
Oswaldo Cruz Foundation
Grifols SA
F. Hoffmann-La Roche Ltd
Siemens AG
Qiagen NV
Trinity Biotech Plc
Frequently asked questions
-
What was the HIV tests market size in 2023?
The HIV tests market size was $1.95 billion in 2023.
-
What will the HIV tests market CAGR be during 2023-2033?
The HIV test market will grow at a CAGR of more than 2% during 2023-2033.
-
Which was the leading segment in the HIV tests market in 2023?
HIV Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests segment was leading the HIV tests market in 2023.
-
Which region held the largest share of the HIV tests market in 2023?
North America was the largest market for HIV tests in 2023.
-
Which are the leading players in the HIV tests market?
The key companies in the HIV tests market are GE Healthcare Technologies Inc, Siemens Healthineers AG, Philips Healthcare, Canon Medical Systems Corp, Hitachi Healthcare Manufacturing Ltd, Samsung Medison Co Ltd, Fujifilm Holdings Corp, Esaote SpA, and Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.